ARYx Therapeutics, Inc. (ARYX)

ARYx Therapeutics Statistics

Total Valuation

ARYX has a market cap or net worth of 33.

Market Cap	33
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ARYX has 33.46 million shares outstanding.

Current Share Class	33.46M
Shares Outstanding	33.46M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.47

Current Ratio	0.47
Quick Ratio	0.38
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.58
Interest Coverage	-8.95

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-74.86%
Return on Invested Capital (ROIC)	-100.50%
Return on Capital Employed (ROCE)	832.53%
Revenue Per Employee	n/a
Profits Per Employee	-327,286
Employee Count	56
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	508.39
52-Week Price Change	n/a
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	41.95
Average Volume (20 Days)	94,348

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.13M
Pretax Income	-18.33M
Net Income	-18.33M
EBITDA	-14.18M
EBIT	-15.13M
Earnings Per Share (EPS)	-0.59

Balance Sheet

The company has 2.95 million in cash and 11.57 million in debt, giving a net cash position of -8.62 million or -0.26 per share.

Cash & Cash Equivalents	2.95M
Total Debt	11.57M
Net Cash	-8.62M
Net Cash Per Share	-0.26
Equity (Book Value)	-7.74M
Book Value Per Share	-0.23
Working Capital	-4.11M

Cash Flow

In the last 12 months, operating cash flow was -20.07 million and capital expenditures -52,000, giving a free cash flow of -20.12 million.

Operating Cash Flow	-20.07M
Capital Expenditures	-52,000
Free Cash Flow	-20.12M
FCF Per Share	-0.60

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARYX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.87%
Shareholder Yield	-17.87%
Earnings Yield	-55,539,393.94%
FCF Yield	-60,972,727.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1